Maria Valdrinez Campana Lonardoni

Dr. Maria Valdrinez Campana Lonardoni

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
VNVanessa Nesi-Reis
Vanessa Nesi-Reis
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
JOJully Oyama
Jully Oyama
MLMarielle Priscila De Paula Silva Lalucci
Marielle Priscila De Paula Silva Lalucci
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

1 October 2011 in Experimental Parasitology
Verified
Journal Article
Closed access
ZGZilda Gazim
Zilda Gazim
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
AAAna Carolina L. Amorim
Ana Carolina L. Amorim
AHAna Maria C. Hovell
Ana Maria C. Hovell
DCDiogenes Aparício Garcia Cortez
Diogenes Aparício Garcia Cortez

1 January 2014 in Experimental Parasitology
Verified
Journal Article
Closed access
TMTatiane F.P. de Mello
Tatiane F.P. de Mello
HBHeriberto R. Bitencourt
Heriberto R. Bitencourt
RPRaíssa Bocchi Pedroso
Raíssa Bocchi Pedroso
SASandra M.A. Aristides
Sandra M.A. Aristides
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
TSThais Silveira
Thais Silveira

1 April 2018 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
TLTarcisio Vitor Augusto Lordani
Tarcisio Vitor Augusto Lordani
CLCelia Eliane de Lara
Celia Eliane de Lara
FFFabiana Borges Padilha Ferreira
Fabiana Borges Padilha Ferreira
MMMariana de Souza Terron Monich
Mariana de Souza Terron Monich
TLTarcisio Lordani
Tarcisio Lordani
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
The pharmaceutical industry has made great strides in providing drugs that are able to stimulate the healing process, but only 1–3% of all drugs that are listed in Western pharmacopoeias are intended for use on the skin or cutaneous wounds. Of these, at least one-third are obtained from plants. We sought to review the therapeutic effects of medicinal plants on human skin lesions. For this systematic review, we searched the PubMed, Scopus, and Web of Science databases to identify clinical trials that were published from 1997 to 2017. We reviewed studies that described the use of medicinal plants for the treatment of skin lesions in humans. Ten studies were selected, eight of which were published from 2007 to 2016, with a total of 503 patients. Among the plant species that were used for the treatment of human skin lesions, 12 belonged to 11 families and were included in the analysis. All of the plant species that were studied presented high therapeutic potential for the treatment of cutaneous lesions.

1 August 2011 in Experimental Parasitology
Verified
Journal Article
Closed access
LPLílian Somenci Peloi
Lílian Somenci Peloi
CBCarlos Eduardo Guerino Biondo
Carlos Eduardo Guerino Biondo
EKElza Kimura
Elza Kimura
MPMario José Politi
Mario José Politi
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
TSThaís Gomes Verzignassi Silveira
Thaís Gomes Verzignassi Silveira

3 April 2017 in Parasitology
Verified
Journal Article
Closed access
PDF file
PNPriscila Wolf Nassif
Priscila Wolf Nassif
TMTatiane França Perles DE Mello
Tatiane França Perles DE Mello
TNTaísa Rocha Navasconi
Taísa Rocha Navasconi
CMCamila Alves Mota
Camila Alves Mota
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
TSThais Silveira
Thais Silveira
SUMMARY: Studies of topical treatments for leishmaniasis were systematically reviewed, to evaluate the therapeutic efficacy, safety and any adverse effects of these treatments. The papers identified in the databases PubMed and Web of Knowledge involved eight studies with a total of 1744 patients. The majority of trials was from Iran (4/8), covered a period of 8 years (2003–2011), and included patients 4–85 years of age. The most frequent Leishmania species in the studies were L. tropica (4/8) and L. major (2/8). The treatments administered were thermotherapy, paromomycin and combinations, CO2 laser, 5-aminolevulinic acid hydrochloride (10%) plus visible red light (633 nm) and cryotherapy. Six articles reported cure rates over 80·0%. Six studies reported on failure rates, three of them reporting rates lower than 10%. Four studies did not report relapses or recurrences, while the other studies reported low rates (1·8–6·3%). The most common adverse effects of the topical treatments were redness/erythema, pain, pruritus burning, oedema, vesicles and hyper- or hypopigmentation. The results provide strong evidence that the treatments topical evaluated showed high cure rates, safety and effectiveness, with low side-effects, relapse and recurrence rates, except for cryotherapy, which showed a moderate cure rate.